The pharmaceutical community is buzzing by retatrutide, a novel dual GIP and GLP-1 target that’s showing remarkable results in clinical studies . This compound works by imitating natural hormones to regulate appetite and boost feelings of satisfaction , ultimately contributing to noticeable body loss . While presently under investigation and not